Gut bacteria may hold key to better transplant outcomes
NCT ID NCT07464483
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how gut bacteria and the immune system interact in children and adults receiving stem cell transplants or CAR-T therapy. Researchers will collect stool and blood samples over time to find patterns linked to complications like infections or graft-versus-host disease. The goal is to use this information to develop better risk prediction and personalized care. No new treatments are being tested; this is an observational study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW REPLACED VIA TRANSPLANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITINGBologna, Bologna, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug cuts chemotherapy side effect by over 60% in breast cancer patients
- New drug shows promise for controlling rare skin cancers
- Asthma drug may ease cancer treatment side effects
- New drug aims to fix Immunotherapy's blood problems in lung cancer
- Massive study to track Real-World safety of new blood disorder drugs